Viewing Study NCT06891066


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-01-25 @ 7:02 AM
Study NCT ID: NCT06891066
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-16
First Post: 2025-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module